Description
DNA PRIMER
First action · last action
2009-07-24 · 2009-07-24
Transactions
1
First transaction's obligation
$3,835
Base + all options value (sum of deltas)
$3,835
Extent competed
NOT COMPETED
Other than full & open authority
UNIQUE SOURCE
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-07-24+$3,835= $3,835
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-07-24 | +$3,835 | $3,835 | DNA PRIMER |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI J6D6NR41SF54)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E23P0098 | RPO EAST (36C24E) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $76,045 | FY2023 |
| 36C24223P0943 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $27,407 | FY2023 |
| VA24115P2024 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6810 · CHEMICALS | $0 | FY2015 |
| VA25112P1002 | 553-DETROIT · 6505 · DRUGS AND BIOLOGICALS | $6,000 | FY2012 |
| VA603D10022 | 249-NETWORK CONTRACT OFFICE 9 · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $9,168 | FY2011 |
| VA662D10233 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $13,807 | FY2011 |
Other recipients under 6505 from 580-HOUSTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0353 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 580-HOUSTON | $5,477 | FY2013 |
| VA25613P0134 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $8,806 | FY2013 |
| VA25612P2546 | MCKESSON PLASMA AND BIOLOGICS LLC | 580-HOUSTON | $10,147 | FY2012 |
| VA25612P2560 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $9,088 | FY2012 |
| VA25612F2494 | ACTELION PHARMACEUTICALS US, INC. | 580-HOUSTON | $4,293 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA580D90049_3600_-NONE-_-NONE- · retrieved 2026-09-26.